Abstract
The most common cause of organic fasting hypoglycemia in adults is the presence of an insulin-producing pancreatic adenoma, but when high insulin levels are not found, the differential diagnosis is challenging. Misdiagnosis can lead to an unnecessary pancreatectomy. Insulin concentrations may be low in some cases despite a clinical history suggestive of insulinoma. In these cases, a proinsulinoma should be suspected, although the rarity of this condition requires an extensive workup before reaching a final diagnosis. We describe an unusual case of a 38-year-old man with a severe hypoglycemic syndrome due to a proinsulin-secreting pancreatic adenoma. Insulin was measured by the specific assay and suppressed under the lower detection limit during fasting hypoglycemia. Serum proinsulin and C-peptide levels were abnormally elevated, and further tests revealed an islet cell tumor. The tumor was surgically removed, relieving the fasting hypoglycemia. Histopathological study showed a conventional well-differentiated neuroendocrine tumor with high immunoreactivity against proinsulin and with lesser intensity against insulin. Interestingly, GS-9A8 antibody clone used for immunostaining proinsulin did not cross-react with human insulin or C-peptide, providing an unbiased picture of proinsulin secretion. The resolution of symptoms, the fall of proinsulin concentrations after tumor removal and the histopathology study confirmed the diagnosis of proinsulinoma.
Similar content being viewed by others
References
Goldin SB, Aston J and Wahi MM. Sporadically occurring functional pancreatic endocrine tumors: review of recent literature. Curr Opin Oncol 20: 1: 25-33, 2008.
Grant CS. Insulinoma. Best Pract Res Clin Gastroenterol 19: 5: 783-798, 2005.
Fadini GP, Maran A, Valerio A, Meduri F, Pelizzo M, Miotto D, Lanza C, Altavilla G and Avogaro A. Hypoglycemic syndrome in a patient with proinsulin-only secreting pancreatic adenoma (proinsulinoma). Case Rep Med 2011: 930904, 2011.
de Herder WW. Biochemistry of neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab 21: 1: 33-41, 2007.
Vinik AI, Woltering EA, Warner RR, Caplin M, O'Dorisio TM, Wiseman GA, Coppola D, Go VL and North American Neuroendocrine Tumor Society (NANETS). NANETS consensus guidelines for the diagnosis of neuroendocrine tumor. Pancreas 39: 6: 713-734, 2010.
Guettier JM, Lungu A, Goodling A, Cochran C and Gorden P. The role of proinsulin and insulin in the diagnosis of insulinoma: a critical evaluation of the Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 98: 12: 4752-4758, 2013.
Creutzfeldt W, Creutzfeldt C, Frerichs H, Track NS and Arnold R. Histochemistry, ultrastructure and hormone content of human insulinomas. Horm Metab Res Suppl 6: 7-18, 1976.
Bendayan M. Possibilities of false immunocytochemical results generated by the use of monoclonal antibodies: the example of the anti-proinsulin antibody. J Histochem Cytochem 43:9:881-886, 1995.
Madsen OD, Cohen RM, Fitch FW, Rubenstein AH and Steiner DF. The production and characterization of monoclonal antibodies specific for human proinsulin using a sensitive microdot assay procedure. Endocrinology 113: 6: 2135-2144, 1983.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict Interest
The authors declare that they have no competing interests.
Rights and permissions
About this article
Cite this article
Pérez-Pevida, B., Idoate, M.Á., Fernández-Landázuri, S. et al. Hypoglycemic Syndrome without Hyperinsulinemia. A Diagnostic Challenge. Endocr Pathol 27, 50–54 (2016). https://doi.org/10.1007/s12022-016-9415-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12022-016-9415-x